JSB Market Research: Infantile Spasms Therapeutics

Page 1

Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 9thDecember 2014

Summary The industry analysis specialist, has released its new report, “Infantile Spasms Therapeutics Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Infantile Spasms Therapeutics market. The report identifies the key trends shaping and driving the global Infantile Spasms Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Infantile Spasms Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-infantile-spasms-therapeutics-pipeline-assessment-and-marketforecasts-135220 Scope The report provides information on the key drivers and challenges of the Infantile Spasms Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Infantile Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/


Spasms Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Infantile Spasms Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Infantile Spasms Therapeutics market. - Analysis of key recent licensing and partnership agreements in Infantile Spasms Therapeutics market

Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Infantile Spasms Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Infantile Spasms Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Infantile Spasms Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/


Other industries we cover: • • • • • • • • •

Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Infantile Spasms Therapeutics - Introduction 2.1 Disease Overview 2.2 Epidemiology 2.2.1 Incidence and Prevalence 2.2.2 Gender 2.2.3 Quality of Life Parameters 2.2.4 Socioeconomic Impact 2.2.5 Mortality 2.3 Etiology 2.4 Pathophysiology 2.5 Signs 2.6 Diagnosis 2.6.1 Step-by-Step Diagnostic Approach 2.7 Treatment and Management Options 2.7.1 First Line Therapy 2.7.2 Second Line Therapy 2.8 Prognosis 2.9 Referral Pathway Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/


2.10 GlobalData Pipeline Report Guidance 3 Infantile Spasms Therapeutics - Market Characterization 3.1 Overview 3.2 Infantile Spasms Therapeutics Market Size (2006-2011) - Global 3.3 Infantile Spasms Therapeutics Market Forecast (2011-2019) - Global 3.4 Infantile Spasms Therapeutics Market Size (2006-2011) - The US 3.5 Infantile Spasms Therapeutics Market Forecast (2011-2019) - The US 3.6 Infantile Spasms Therapeutics Market Size (2006-2011) - France 3.7 Infantile Spasms Therapeutics Market Forecast (2011-2019) - France 3.8 Infantile Spasms Therapeutics Market Size (2006-2011) - Germany 3.9 Infantile Spasms Therapeutics Market Forecast (2011-2019) - Germany 3.10 Infantile Spasms Therapeutics Market Size (2006-2011) - Italy 3.11 Infantile Spasms Therapeutics Market Forecast (2011-2019) - Italy 3.12 Infantile Spasms Therapeutics Market Size (2006-2011) - Spain 3.13 Infantile Spasms Therapeutics Market Forecast (2011-2019) - Spain 3.14 Infantile Spasms Therapeutics Market Size (2006-2011) - The UK 3.15 Infantile Spasms Therapeutics Market Forecast (2011-2019) - The UK 3.16 Infantile Spasms Therapeutics Market Size (2006-2011) - Japan 3.17 Infantile Spasms Therapeutics Market Forecast (2011-2019) - Japan 3.18 Drivers and Barriers for the Infantile Spasms Therapeutics Market 3.18.1 Drivers for the Infantile Spasms Therapeutics Market 3.18.2 Barriers for the Infantile Spasms Therapeutics Market 3.19 Opportunity and Unmet Need Analysis 3.20 Key Takeaway 4 Infantile Spasms Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Infantile Spasms Market 4.3.1 H.P. Acthar Gel (Repository Corticotropin Injection, ACTH) 4.3.2 Sabril (vigabatrin) 4.4 Key Takeaway 5 Infantile Spasms Therapeutics - Pipeline Assessment 5.1 Overview 6 Infantile Spasms Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Overall Sponsors 7 Strategic Assessment Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/


7.1 Key Events Impacting the Future Market 7.2 Infantile Spasms Therapeutics: Implications for Future Market Competition 8 Infantile Spasms Therapeutics - Current Players 8.1 Introduction 8.2 Company Profiles 8.2.1 H Lundbeck A/S 8.2.2 Questcor Pharmaceuticals, Inc. 9 Infantile Spasms Therapeutics - Appendix 9.1 Market Definitions 9.2 Abbreviations 9.3 Methodology 9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography

List Of Tables Table 1: Infantile Spasms Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 2: Infantile Spasms Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 3: Infantile Spasms Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 4: Infantile Spasms Therapeutics Market, The US, Forecast ($m), 2011-2019 Table 5: Infantile Spasms Therapeutics Market, France, Revenue ($), 2006-2011 Table 6: Infantile Spasms Therapeutics Market, France, Forecast ($), 2011-2019 Table 7: Infantile Spasms Therapeutics Market, Germany, Revenue ($), 2006-2011 Table 8: Infantile Spasms Therapeutics Market, Germany, Forecast ($), 2011-2019 Table 9: Infantile Spasms Therapeutics Market, Italy, Revenue ($), 2006-2011 Table 10: Infantile Spasms Therapeutics Market, Italy, Forecast ($), 2011-2019 Table 11: Infantile Spasms Therapeutics Market, Spain, Revenue (1,000$), 2006-2011 Table 12: Infantile Spasms Therapeutics Market, Spain, Forecast ($), 2011-2019 Table 13: Infantile Spasms Therapeutics Market, The UK, Revenue ($), 2006-2011 Table 14: Infantile Spasms Therapeutics Market, The UK, Forecast ($), 2011-2019 Table 15: Infantile Spasms Therapeutics Market, Japan, Revenue ($), 2006-2011 Table 16: Infantile Spasms Therapeutics Market, Japan, Forecast ($), 2011-2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/


Table 17: Spasm Freedom by Primary Criteria Table 18: Infantile Spasms Therapeutics- Pre-Clinical Pipeline, 2011 Table 19: Infantile Spasms Therapeutics, Clinical Trials by Country, 2011 Table 20: Infantile Spasms Therapeutics, Clinical Trials by Phase, 2011 Table 21: Infantile Spasms Therapeutics, Clinical Trials by Status of Development, 2011 Table 22: Infantile Spasms Therapeutics, Overall Sponsors, 2011 Table 23: H Lundbeck A/S, Central Nervous System Pipeline, 2011

List Of Figures Figure 1: Overview of Etiologies, Converged Pathophysiologies and Signs of Infantile Spasms Figure 2: Ash Leaf Macules- in a Child with Tuberous Sclerosis Figure 3: Examples of Human Hypsarrhythmic EEGs and Electrodecrements Figure 4: Diagnostic Work-up Plan for Identification of Infantile Spasms Figure 5: Treatment Paradigm for Infantile Spasms Figure 6: Referral Pathway Figure 7: Infantile Spasms Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 8: Infantile Spasms Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 9: Infantile Spasms Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 10: Infantile Spasms Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 11: Infantile Spasms Therapeutics Market, France, Revenue ($), 2006-2011 Figure 12: Infantile Spasms Therapeutics Market, France, Forecast ($), 2011-2019 Figure 13: Infantile Spasms Therapeutics Market, Germany, Revenue ($), 2006-2011 Figure 14: Infantile Spasms Therapeutics Market, Germany, Forecast ($), 2011-2019 Figure 15: Infantile Spasms Therapeutics Market, Italy, Revenue ($), 2006-2011 Figure 16: Infantile Spasms Therapeutics Market, Italy, Forecast ($), 2011-2019 Figure 17: Infantile Spasms Therapeutics Market, Spain, Revenue ($), 2006-2011 Figure 18: Infantile Spasms Therapeutics Market, Spain, Forecast ($), 2011-2019 Figure 19: Infantile Spasms Therapeutics Market, The UK, Revenue ($), 2006-2011 Figure 20: Infantile Spasms Therapeutics Market, The UK, Forecast ($), 2011-2019 Figure 21: Infantile Spasms Therapeutics Market, Japan, Revenue ($), 2006-2011 Figure 22: Infantile Spasms Therapeutics Market, Japan, Forecast ($), 2011-2019 Figure 23: Opportunity and Unmet Need in the Infantile Spasms Therapeutics Market, 2011 Figure 24: Infantile Spasms Therapeutics, Strategic Competitor Assessment, 2011 Figure 25: Infantile Spasms Therapeutics, Clinical Trials by Status of Development, 2011 Figure 26: Infantile Spasms Therapeutics, Overall Sponsors, 2011 Figure 27: Infantile Spasms Therapeutics Market, Drivers and Barriers, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/


Figure 28: Implications for Future Market Competition in the Infantile Spasms, 2011 Figure 29: GlobalData Market Forecasting Model

Report Price: Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports: Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/


About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.

To know more on Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-infantile-spasmstherapeutics-pipeline-assessment-and-market-forecasts-135220

Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.